Publications by authors named "Maroof A"

Background: Early identification of developmental delay in children can help in making early intervention for its management. Routine developmental screening is not being practised in India due to lack of trained field workers, lack of awareness among parents and lack of feasible assessment screening tool. There is lack of studies that focuses on home environment provided to the children as it is associated with developmental delay.

View Article and Find Full Text PDF

Objectives: The main purpose of this study was to determine the frequency of COVID-19 vaccine side effects in patients with rheumatic diseases and to examine any potential associations with medications, disease type, or comorbidities.

Methods: A multicentre cross-sectional study from rheumatology units in different hospitals in Iraq was carried out between 8 of August 2021 and 4th of August 2022. Patients were eligible for inclusion if they have a rheumatic disease and have taken one or more doses of any COVID-19 vaccine.

View Article and Find Full Text PDF
Article Synopsis
  • * The study involved 554 patients from 13 Arab countries, validating the Arabic version of the PsAID-12 with strong internal consistency (Cronbach's α = 0.95) and substantial test-retest reliability (ICC 0.90).
  • * Key factors linked to higher PsAID-12 scores included disability, depression, widespread pain, and disease activity, highlighting pain and fatigue as critical concerns for patients with psoriatic arthritis.
View Article and Find Full Text PDF

JAK/STAT signaling pathway plays a significant role in cytokines and growth factors signaling involved in the pathogenesis of rheumatoid arthritis (RA). STAT3 is a major downstream signaling mediator of important pro-inflammatory cytokines involved in Th-17 cell differentiation playing a significant role in regulating Th-17/ Treg balance and the development of autoimmune diseases, especially RA. Studies also have reported the role of the STAT3 pathway in inflammatory and destructive functions of synovial fibroblasts (SFs) in RA.

View Article and Find Full Text PDF
Article Synopsis
  • * The study found that rozanolixizumab can bind to Fc gamma receptors (FcγRs) and mediate a process called antibody bipolar bridging, which influences macrophage surface proteins, but this effect can be inhibited by the presence of human IgG.
  • * Importantly, experiments showed that rozanolixizumab's binding to its receptors did not trigger cellular activation, raising questions about its actual engagement with FcγRs in clinical settings where competing IgG is present.
View Article and Find Full Text PDF
Article Synopsis
  • IL-17A is known to play a significant role in immune-mediated inflammatory diseases, while the function of IL-17F, which shares some similarity with IL-17A, is not well understood, though combining the inhibition of both shows potential benefits in treating psoriasis.
  • In this study, researchers investigated how IL-17A and IL-17F are regulated in psoriatic disease using various advanced techniques, including RNA sequencing and a new cytokine-capture method.
  • The findings highlight that IL-17F is expressed more than IL-17A in psoriatic conditions, with differing cell populations responsible for each isoform and their expression influenced by both inflammatory signals and medications, suggesting a need to target both IL-
View Article and Find Full Text PDF

Introduction Obesity has emerged as a major public health issue in both developed and developing countries. The prevalence of obesity is on the rise. Bariatric surgery is acknowledged as the most effective and safe solution for this problem.

View Article and Find Full Text PDF

Objective: To assess the value of referral strategies for axial spondyloarthritis (axSpA) in patients with suspicious chronic inflammatory low back pain (LBP), to estimate the value of inflammatory back pain (IBP) for referral, and to identify the predictive factors of the final diagnosis of axSpA in Middle Eastern Arab countries.

Methods: The study was multicentric, prospective, and conducted in LBP first-line clinics (rheumatology, internal, family medicine, orthopedic surgery, neurosurgery, and neurology). Consecutive adult patients aged under 45years were included in case of LBP suspicious of inflammatory nature according to the first-line physician.

View Article and Find Full Text PDF

TrYbe® is an Fc-free therapeutic antibody format, capable of engaging up to three targets simultaneously, with long half-life conferred by albumin binding. This format is shown by small-angle X-ray scattering to be conformationally flexible with favorable 'reach' properties. We demonstrate the format's broad functionality by co-targeting of soluble and cell surface antigens.

View Article and Find Full Text PDF
Article Synopsis
  • Bimekizumab is a monoclonal antibody targeting interleukin (IL)-17A and IL-17F, undergoing trials for moderate-to-severe plaque psoriasis, with established maintenance dosing every 4 weeks.
  • In a study with 49 patients, 320 mg of bimekizumab was administered at specific intervals, showing significant improvement in psoriasis severity, with a peak efficacy seen around week 12.
  • Notably, the treatment not only led to clinical improvements but also normalized skin-related gene expressions, indicating a positive change in the skin's biological state, thus supporting further investigation into shorter maintenance dosing intervals.
View Article and Find Full Text PDF

Objectives: A number of immune populations have been implicated in psoriatic arthritis (PsA) pathogenesis. This study used mass cytometry (CyTOF) combined with transcriptomic analysis to generate a high-dimensional dataset of matched PsA synovial fluid (SF) and blood leucocytes, with the aim of identifying cytokine production ex vivo in unstimulated lymphoid and myeloid cells.

Methods: Fresh SF and paired blood were either fixed or incubated with protein transport inhibitors for 6 hours.

View Article and Find Full Text PDF

IL-23 is considered a critical regulator of IL-17 in Th17 cells; however, its requirement for inducing IL-17 production in other human immune subsets remains incompletely understood. Mucosal associated invariant T (MAIT) cells uniformly express retinoic acid receptor-related orphan receptor gamma t (RORγt) but only a minor population have been shown to produce IL-17A. Here we show that IL-17F is the dominant IL-17 isoform produced by MAIT cells, not IL-17A.

View Article and Find Full Text PDF
Article Synopsis
  • Interleukin (IL)-17A plays a critical role in inflammation and is a target for treatments using monoclonal antibodies, particularly in diseases like psoriasis and psoriatic arthritis.
  • Researchers developed a humanized antibody, 496.g3, which improved the binding capability to both IL-17A and IL-17F, demonstrating greater efficacy than existing treatments.
  • Early clinical studies of 496.g3, now called bimekizumab, show promising results in treating various IL-17-mediated inflammatory diseases, indicating potential benefits of targeting both IL-17A and IL-17F simultaneously.
View Article and Find Full Text PDF

Psoriatic arthritis (PsA) is a debilitating immune-mediated inflammatory arthritis of unknown pathogenesis commonly affecting patients with skin psoriasis. Here we use complementary single-cell approaches to study leukocytes from PsA joints. Mass cytometry demonstrates a 3-fold expansion of memory CD8 T cells in the joints of PsA patients compared to peripheral blood.

View Article and Find Full Text PDF

Objectives: Interleukin (IL)-17 signalling has been shown to be a key regulator of disease in ankylosing spondylitis (AS) with several IL-17 blockers currently clinically approved. Despite this, the role of IL-17 in bone pathology is poorly understood. This study aimed to investigate IL-17 signalling in the context of pathological bone formation.

View Article and Find Full Text PDF

The pro-inflammatory cytokine IL-17A has been implicated in the immunopathology of inflammatory arthritis. IL-17F bears 50% homology to IL-17A and has recently been suggested to play a role in inflammation. We investigated the induction and cytokine profile of IL-17F CD4 T cells, and how IL-17F may contribute to inflammation.

View Article and Find Full Text PDF
Article Synopsis
  • Initiation of adaptive immunity involves distinct cell populations migrating to specific sites, but tracking these movements has been challenging due to limitations in current methods.
  • Researchers utilized photo-convertible transgenic mice to gain insights into the cell populations that leave the site of skin priming and enter the draining lymph node, revealing that most migratory cells were recruited to the priming site during inflammation.
  • The study provides a comprehensive map of cell dynamics and characteristics during immune response activation, highlighting important cell types like dendritic cells and T cells, and offering valuable information for improving immunotherapy strategies in autoimmunity and vaccination.
View Article and Find Full Text PDF

The ventral tegmental area (VTA) is a heterogeneous midbrain structure, containing neurons and astrocytes, that coordinates behaviors by integrating activity from numerous afferents. Within neuron-astrocyte networks, astrocytes control signals from distinct afferents in a circuit-specific manner, but whether this capacity scales up to drive motivated behavior has been undetermined. Using genetic and optical dissection strategies we report that VTA astrocytes tune glutamatergic signaling selectively on local inhibitory neurons to drive a functional circuit for learned avoidance.

View Article and Find Full Text PDF

While the etiology of multiple sclerosis (MS) remains unclear, research from the clinic and preclinical models identified the essential role of inflammation and demyelination in the pathogenesis of MS. Current treatments focused on anti-inflammatory processes are effective against acute episodes and relapsing-remitting MS, but patients still move on to develop secondary progressive MS. MS progression is associated with activation of microglia and astrocytes, and importantly, metabolic dysfunction leading to neuronal death.

View Article and Find Full Text PDF

Objective: To determine whether intraoperative local injection of 0.5% bupivacaine around port sites would decrease early postoperative pain after laparoscopic cholecystectomy, and the use of intravenous opioid analgesics postoperatively.

Study Design: Randomised controlled trial.

View Article and Find Full Text PDF
Article Synopsis
  • IL-17A is crucial for inflammation in immune diseases, but the role of IL-17F is less understood; the study hypothesizes that both contribute to chronic inflammation and that targeting both may be more effective.
  • Preclinical tests showed that IL-17F triggers similar inflammatory reactions as IL-17A, and the clinical trial of bimekizumab (a drug neutralizing both IL-17A and IL-17F) demonstrated better inflammation control compared to targeting IL-17A alone.
  • Results from the trial indicate that dual inhibition significantly improved patient outcomes in psoriatic arthritis by reducing symptoms in skin and joints, supporting the importance of IL-17F in inflammatory processes.
View Article and Find Full Text PDF

During development, axons spontaneously assemble into a fascicle to form nerves and tracts in the nervous system as they extend within a spatially constrained path. However, understanding of the axonal fascicle has been hampered by lack of an in vitro model system. Here, we report generation of a nerve organoid composed of a robust fascicle of axons extended from a spheroid of human stem cell-derived motor neurons within our custom-designed microdevice.

View Article and Find Full Text PDF